TREACE MEDICAL CONCEPTS, INC.
TMCITreace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How TMCI's past catalysts played out
No drugs found in this phase.
Frequently asked questions
When is TREACE MEDICAL CONCEPTS, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for TREACE MEDICAL CONCEPTS, INC. (TMCI) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track TMCI biotech catalysts?→
Add TMCI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow TREACE MEDICAL CONCEPTS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.